During the past decade, Retina Specialists conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 7 clinical trials were completed, i.e. on average, 70% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 7 clinical trials were completed. i.e. 233.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Retina Specialists" #1 sponsor was "Genentech, Inc." with 3 trials, followed by "Hoffmann-La Roche" with 3 trials sponsored, "ThromboGenics" with 2 trials sponsored, "Apellis Pharmaceuticals, Inc." with 1 trials sponsored and "Clearside Biomedical, Inc." with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

According to Clinical.Site data, the most researched conditions in "Retina Specialists" are "Diabetic Macular Edema" (2 trials), "Geographic Atrophy" (2 trials), "Age-Related Macular Degeneration" (1 trials), "Macular Degeneration" (1 trials) and "Macular Edema" (1 trials). Many other conditions were trialed in "Retina Specialists" in a lesser frequency.

Most popular intervention types in "Retina Specialists" are "Drug" (8 trials), "Other" (3 trials) and "Procedure" (2 trials). Other intervention types were less common.

The name of intervention was led by "Aflibercept" (3 trials), "Faricimab" (3 trials), "Sham Procedure" (3 trials), "Drug: GB-102" (1 trials) and "Lampalizumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Retina Specialists" are 11 trials for "All" genders.

Currently, there are NaN active trials in "Retina Specialists". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in Retina Specialists, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Retina Specialists, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".